^
    over2years
    CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma (clinicaltrials.gov)
    P1, N=24, Recruiting, iCell Gene Therapeutics | Trial completion date: Oct 2023 --> Jun 2024 | Initiation date: Nov 2021 --> Jul 2022 | Trial primary completion date: Oct 2023 --> Jun 2024
    Trial completion date • Trial initiation date • Trial primary completion date • CAR T-Cell Therapy
    |
    CD7 (CD7 Molecule)
    |
    CD7 CAR-T Cell
    almost3years
    CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma (clinicaltrials.gov)
    P1, N=24, Recruiting, iCell Gene Therapeutics
    New P1 trial • CAR T-Cell Therapy
    |
    CD7 (CD7 Molecule)
    |
    CD7 CAR-T Cell